DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

9.07 0.23 (2.55%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARIA $9.07 2.55%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.85
Previous Close $8.84
Daily Range $8.82 - $9.07
52-Week Range $4.90 - $9.89
Market Cap $1.7B
P/E Ratio -10.05
Dividend (Yield) $0.00 (0.0%)
Volume 2,855,434
Average Daily Volume 5,275,103
Current FY EPS -$1.10

Sector

Healthcare

Industry

Drug Makers

Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website: http://www.ariad.com/

News & Commentary

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

Michael Price Invests in 11 Companies in First Quarter

Stifel Talks 5 Biotech Stocks

ARIAD (ARIA) Q1 Loss Wider than Estimates; Iclusig Grows - Analyst Blog

ARIAD (ARIA) Q1 Loss Wider than Estimates; Iclusig Grows - Analyst Blog

ARIAD (ARIA) Q1 Loss a Penny Wider than Expected - Tale of the Tape

ARIAD Pharmaceuticals (ARIA) Harvey J. Berger on Q1 2015 Results - Earnings Call Transcript

Interesting ARIA Put Options For June 26th

ARIAD Pharmaceuticals (ARIA) Q1 2015 Results - Earnings Call Webcast

Health Care Sector Update for 05/06/2015: NXTM, PGNX, ARIA

Will ARIAD's (ARIA) Iclusig Drive Sales this Earnings? - Analyst Blog

See More ARIA News...

ARIA's Top Competitors

ARIA $9.07 (2.55%)
Current stock: ARIA
GILD $111.71 (0.44%)
Current stock: GILD
CELG $116.09 (-0.09%)
Current stock: CELG
AMGN $163.59 (-0.15%)
Current stock: AMGN